KLK3 and prostate carcinoma: Prostate cancer is usually identified by a blood test to measure prostate-specific antigen levels (PAS), (PSA > 4 ng/ml), a glycoprotein normally expressed by prostate tissue and/or digital rectal examination (Rebello et al., 2021).